Argyle Capital Management’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.76M | Sell |
38,995
-400
| -1% | -$29.9K | 0.9% | 41 |
|
|
2025
Q4 | $3.11M | Buy |
39,395
+1,742
| +5% | +$138K | 1.04% | 37 |
|
|
2025
Q3 | $3.1M | Hold |
37,653
| – | – | 1.07% | 35 |
|
|
2025
Q2 | $3.03M | Buy |
37,653
+450
| +1% | +$34.7K | 1.1% | 34 |
|
|
2025
Q1 | $2.99M | Buy |
37,203
+1,720
| +5% | +$143K | 1.11% | 36 |
|
|
2024
Q4 | $2.91M | Buy |
35,483
+1,483
| +4% | +$123K | 1.14% | 36 |
|
|
2024
Q3 | $2.8M | Sell |
34,000
-1,575
| -4% | -$118K | 1.12% | 34 |
|
|
2024
Q2 | $2.5M | Sell |
35,575
-50
| -0.1% | -$3.57K | 1.03% | 39 |
|
|
2024
Q1 | $2.64M | Sell |
35,625
-1,900
| -5% | -$132K | 1.02% | 42 |
|
|
2023
Q4 | $2.48M | Sell |
37,525
-9,200
| -20% | -$576K | 1.03% | 40 |
|
|
2023
Q3 | $2.94M | Hold |
46,725
| – | – | 1.08% | 36 |
|
|
2023
Q2 | $2.64M | Sell |
46,725
-2,050
| -4% | -$114K | 0.95% | 39 |
|
|
2023
Q1 | $2.83M | Sell |
48,775
-200
| -0.4% | -$13.5K | 0.99% | 40 |
|
|
2022
Q4 | $3.54M | Sell |
48,975
-1,500
| -3% | -$107K | 1.22% | 31 |
|
|
2022
Q3 | $3.07M | Hold |
50,475
| – | – | 1.2% | 33 |
|
|
2022
Q2 | $3.17M | Hold |
50,475
| – | – | 1.14% | 37 |
|
|
2022
Q1 | $3.55M | Sell |
50,475
-3,400
| -6% | -$230K | 1.15% | 37 |
|
|
2021
Q4 | $3.37M | Hold |
53,875
| – | – | 1.05% | 42 |
|
|
2021
Q3 | $3.33M | Buy |
53,875
+50
| +0.1% | +$3.01K | 1.1% | 42 |
|
|
2021
Q2 | $3.22M | Hold |
53,825
| – | – | 1.04% | 44 |
|
|
2021
Q1 | $3.27M | Hold |
53,825
| – | – | 1.1% | 40 |
|
|
2020
Q4 | $2.53M | Hold |
53,825
| – | – | 0.94% | 46 |
|
|
2020
Q3 | $2M | Buy |
53,825
+2,500
| +5% | +$94.9K | 0.82% | 50 |
|
|
2020
Q2 | $1.87M | Hold |
51,325
| – | – | 0.79% | 50 |
|
|
2020
Q1 | $1.57M | Hold |
51,325
| – | – | 0.74% | 50 |
|
|
2019
Q4 | $2.62M | Sell |
51,325
-700
| -1% | -$33.8K | 0.93% | 48 |
|
|
2019
Q3 | $2.45M | Sell |
52,025
-200
| -0.4% | -$9.54K | 0.93% | 49 |
|
|
2019
Q2 | $2.59M | Hold |
52,225
| – | – | 0.98% | 48 |
|
|
2019
Q1 | $2.22M | Hold |
52,225
| – | – | 0.85% | 50 |
|
|
2018
Q4 | $2.14M | Buy |
52,225
+1,500
| +3% | +$64.4K | 0.91% | 47 |
|
|
2018
Q3 | $2.37M | Buy |
50,725
+1,000
| +2% | +$45.7K | 0.89% | 45 |
|
|
2018
Q2 | $2.17M | Buy |
49,725
+400
| +0.8% | +$18.6K | 0.86% | 51 |
|
|
2018
Q1 | $2.26M | Sell |
49,325
-2,100
| -4% | -$102K | 0.9% | 50 |
|
|
2017
Q4 | $2.6M | Hold |
51,425
| – | – | 0.97% | 47 |
|
|
2017
Q3 | $2.67M | Sell |
51,425
-6,274
| -11% | -$306K | 1.05% | 42 |
|
|
2017
Q2 | $2.83M | Sell |
57,699
-561
| -1% | -$26K | 1.15% | 38 |
|
|
2017
Q1 | $2.74M | Buy |
58,260
+561
| +1% | +$26.7K | 1.12% | 41 |
|
|
2016
Q4 | $2.77M | Sell |
57,699
-1,010
| -2% | -$46.3K | 1.18% | 36 |
|
|
2016
Q3 | $2.33M | Sell |
58,709
-1,234
| -2% | -$46.4K | 1.01% | 45 |
|
|
2016
Q2 | $2.13M | Buy |
59,943
+7,742
| +15% | +$302K | 0.9% | 48 |
|
|
2016
Q1 | $2.04M | Buy |
52,201
+2,356
| +5% | +$88.1K | 0.93% | 46 |
|
|
2015
Q4 | $2.14M | Sell |
49,845
-28
| -0.1% | -$1.23K | 0.99% | 44 |
|
|
2015
Q3 | $2.1M | Buy |
49,873
+1,459
| +3% | +$68.2K | 1.02% | 42 |
|
|
2015
Q2 | $2.42M | Sell |
48,414
-674
| -1% | -$31.9K | 1.11% | 39 |
|
|
2015
Q1 | $2.21M | Hold |
49,088
| – | – | 0.99% | 46 |
|
|
2014
Q4 | $2.37M | Buy |
49,088
+1,459
| +3% | +$69.3K | 1.04% | 39 |
|
|
2014
Q3 | $2.28M | Hold |
47,629
| – | – | 1.05% | 42 |
|
|
2014
Q2 | $2.36M | Buy |
+47,629
| New | +$2.23M | 1.1% | 40 |
|
Other funds holding MET
VCM
VPM
Argyle Capital Management's MET Position: Q1 2026 in Review
Argyle Capital Management reduced its MetLife (MET) stake by 1% in Q1 2026, selling an estimated $29.9K and leaving 38,995 shares worth $2.76M. The position accounts for 0.9% of the portfolio, ranked #41.
Argyle Capital Management first reported a position in MET in Q2 2014 and has held it in 48 quarters since. The position peaked at $3.55M in Q1 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.
- Argyle Capital Management held 38,995 shares of MetLife worth $2.76M as of Q1 2026.
- Argyle Capital Management sold 400 MetLife shares in Q1 2026, an estimated $29.9K.
- MetLife made up 0.9% of Argyle Capital Management's portfolio in Q1 2026, its #41 holding.
- Argyle Capital Management first reported a position in MetLife in Q2 2014 and has held it in 48 quarters since.
- Argyle Capital Management's MetLife position peaked at $3.55M in Q1 2022.
- 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.
Based on Argyle Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.